Equity Capital Markets
Asia (ex Japan) ECM volume stands at $2.4bn via 16 deals so far this week compared to the $3.4bn via 22 deals completed in the previous week.
Korean issuer Celltrion Inc completed a $792m follow-on via Credit Suisse and Citi in what is the largest Asia (ex Japan) ECM transaction this week.
Asia (ex Japan) Healthcare ECM volume stands at $190.5bn via 1,370 deals in 2018 YTD, down from $219.8bn via 1,720 deals in the same 2017 period and the lowest YTD volume since 2014 ($181.8bn).
Goldman Sachs leads Asia (ex Japan) ECM market with $15.2bn, followed by Citi with $12.5bn and Morgan Stanley with $11.6bn.
| 1 | Goldman Sachs | 14,977.6 | 62 | 8.27 |
| 2 | Citi | 12,113.4 | 70 | 6.57 |
| 3 | Morgan Stanley | 11,396.3 | 49 | 6.21 |
| 4 | China International Capital Corp Ltd | 10,502.0 | 38 | 5.76 |
| 5 | China Securities Co Ltd | 9,613.8 | 41 | 5.32 |
Debt Capital Markets
Asia (ex Japan) international DCM totaled $2.7bn via 6 deals this week, compared to $7.0bn via 20 deals in the previous week.
The largest deal of the week goes to TNB Global Ventures Capital with $750m proceeds via BNP Paribas, CIMB, Citi, and HSBC.
In Asia (ex Japan) International DCM, Euro-denominated bond issuance has reached its largest with $22.0bn via 56 deals compared to second largest in 2017 YTD with $16.6bn via 30 deals. This contrasts with decreasing USD-denominated bond issuance this YTD with $200.0bn via 422 deals compared to $267.0 deals via 465 deals in 2017 YTD.
HSBC leads the Asia (ex Japan) international DCM league with $23.0bn. This is followed by Citi with $16.0bn and Standard Chartered Bank with $12.6bn.
| 1 | HSBC | 22,497.5 | 194 | 8.37 |
| 2 | Citi | 15,506.7 | 121 | 6.01 |
| 3 | Standard Chartered Bank | 12,316.4 | 118 | 4.54 |
| 4 | Bank of China | 11,204.9 | 119 | 4.24 |
| 5 | DBS | 10,021.8 | 97 | 3.78 |
